Dialysis and Anti-diabetic Drugs &nb sp;
| | | To ensure that you never miss an issue, please whitelist us. |
|
|
| | This study aims to test the hypothesis that “younger age at diabetes onset/diagnosis increases susceptibility to chronic kidney disease beyond the effect of longer diabetes duration. This hypothesis was tested by using data from both territory-wide population-based and hospital registry-based diabetes cohorts. |
|
|
It is unknown if choosing a different medication or use of insulin will impact the mortality of dialysis patients with type 2 diabetes. For this study, 5,249 patients were evaluated and placed into three groups: “pre-existing diabetes dialysis (PDD), incident diabetes after dialysis (IDD), and non-diabetic dialysis (NDD)” (Ou et al.). |
| | |
| |
| |
Metformin use and lifestyle modifications have been researched to reduce the likelihood of a patient who had GDM developing T2DM. However, each intervention alone has not shown promising results. The combination of metformin and lifestyle changes, in extensive prospective studies, has been indicated to prove effective in preventing disease progression. |
| | |
|
|
|
